PSA control following definitive therapy for clinically localized prostate cancer

A. D'Amico, M. Garnick, N. Stone, J. Sylvester, David Grignon, P. Albertsen, J. Trachtenberg, L. Goldenberg, W. Fair

Research output: Contribution to journalArticle

Abstract

The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.

Original languageEnglish (US)
Pages (from-to)207-215
Number of pages9
JournalMolecular Urology
Volume3
Issue number3
StatePublished - 1999
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Radiation
Brachytherapy
Prostate-Specific Antigen
Magnetic Resonance Spectroscopy
Quality of Life
Therapeutics
Serum

ASJC Scopus subject areas

  • Urology

Cite this

D'Amico, A., Garnick, M., Stone, N., Sylvester, J., Grignon, D., Albertsen, P., ... Fair, W. (1999). PSA control following definitive therapy for clinically localized prostate cancer. Molecular Urology, 3(3), 207-215.

PSA control following definitive therapy for clinically localized prostate cancer. / D'Amico, A.; Garnick, M.; Stone, N.; Sylvester, J.; Grignon, David; Albertsen, P.; Trachtenberg, J.; Goldenberg, L.; Fair, W.

In: Molecular Urology, Vol. 3, No. 3, 1999, p. 207-215.

Research output: Contribution to journalArticle

D'Amico, A, Garnick, M, Stone, N, Sylvester, J, Grignon, D, Albertsen, P, Trachtenberg, J, Goldenberg, L & Fair, W 1999, 'PSA control following definitive therapy for clinically localized prostate cancer', Molecular Urology, vol. 3, no. 3, pp. 207-215.
D'Amico A, Garnick M, Stone N, Sylvester J, Grignon D, Albertsen P et al. PSA control following definitive therapy for clinically localized prostate cancer. Molecular Urology. 1999;3(3):207-215.
D'Amico, A. ; Garnick, M. ; Stone, N. ; Sylvester, J. ; Grignon, David ; Albertsen, P. ; Trachtenberg, J. ; Goldenberg, L. ; Fair, W. / PSA control following definitive therapy for clinically localized prostate cancer. In: Molecular Urology. 1999 ; Vol. 3, No. 3. pp. 207-215.
@article{60d44df97cea4b7ea5a32d5175ca285d,
title = "PSA control following definitive therapy for clinically localized prostate cancer",
abstract = "The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.",
author = "A. D'Amico and M. Garnick and N. Stone and J. Sylvester and David Grignon and P. Albertsen and J. Trachtenberg and L. Goldenberg and W. Fair",
year = "1999",
language = "English (US)",
volume = "3",
pages = "207--215",
journal = "Molecular Urology",
issn = "1091-5362",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - PSA control following definitive therapy for clinically localized prostate cancer

AU - D'Amico, A.

AU - Garnick, M.

AU - Stone, N.

AU - Sylvester, J.

AU - Grignon, David

AU - Albertsen, P.

AU - Trachtenberg, J.

AU - Goldenberg, L.

AU - Fair, W.

PY - 1999

Y1 - 1999

N2 - The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.

AB - The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.

UR - http://www.scopus.com/inward/record.url?scp=0032760153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032760153&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032760153

VL - 3

SP - 207

EP - 215

JO - Molecular Urology

JF - Molecular Urology

SN - 1091-5362

IS - 3

ER -